Dr. Reckeweg ReVet RV 18
Dr. Reckeweg ReVet RV 18
Authorised
- Berberis vulgaris C4
- LYCOPODIUM CLAVATUM C9
- LYTTA VESICATORIA C6
- Sabal serrulata C4
Product identification
Medicine name:
Dr. Reckeweg ReVet RV 18
Active substance:
- Berberis vulgaris C4
- LYCOPODIUM CLAVATUM C9
- LYTTA VESICATORIA C6
- Sabal serrulata C4
Target species:
-
Cat
-
Dog
-
Amphibians
-
Reptile
-
Mustelids
-
Rabbit
-
Mouse
-
Rat
-
Guinea pig
-
Chicken
-
Turkey
-
Goose
-
Duck
-
Pigeon
-
Ornamental bird
-
Carp
-
Trout
-
Goat
-
Sheep
-
Pig
-
Horse
-
Cattle
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Berberis vulgaris C42.50/milligram(s)1.00gram(s)
-
LYCOPODIUM CLAVATUM C92.50/milligram(s)1.00gram(s)
-
LYTTA VESICATORIA C62.50/milligram(s)1.00gram(s)
-
Sabal serrulata C42.50/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Granules
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Sweden
Package description:
- Available only in Swedish
Additional information
Entitlement type:
-
Homeopathic Registration
Marketing authorisation holder:
- Biosan AB
Marketing authorisation date:
Manufacturing sites for batch release:
- Pharmazeutische Fabrik Dr. Reckeweg & Co. GmbH
Responsible authority:
- Swedish Medical Products Agency
Authorisation number:
- 38004
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet